Abstract:Rationale: Excessive myocardial fibrosis is the main pathological process in the development of cardiac remodeling and heart failure; therefore, it is important to prevent excessive myocardial fibrosis. We determined that microRNA-378 (miR-378) is cardiac-enriched and highly repressed during cardiac remodeling. We therefore proposed that miR-378 has a critical role in regulation of cardiac fibrosis, and examined the effects of miR-378 on cardiac fibrosis after mechanical stress. Methods: Mechanical stress was respectively imposed on mice through a transverse aortic constriction (TAC) procedure and on cardiac fibroblasts by stretching silicon dishes. A chemically modified miR-378 mimic (Agomir) or an inhibitor (Antagomir) was administrated to mice by intravenous injection and to cells by direct addition to the culture medium. MiR-378 knockout mouse was constructed. Cardiac fibroblasts were cultured in the conditioned media from the cardiomyocytes with either miR-378 depletion or treatment with sphingomyelinase inhibitor GW4869. Quantitative real-time polymerase chain reaction analysis of gene and miRNA expression, Western blot analysis, immunochemistry and electron microscopy were performed to elucidate the mechanisms. Results: Mechanical stress induced significant increases in fibrotic responses, including myocardial fibrosis, fibroblast hyperplasia, and protein and gene expression of collagen and matrix metalloproteinases (MMPs) both in vivo and in vitro. All these fibrotic responses were attenuated by treatment with a chemically modified miR-378 mimic (Agomir) but were exaggerated by treatment with an inhibitor (Antagomir). MiR-378 knockout mouse models exhibited aggravated cardiac fibrosis after TAC. Media from the cardiomyocytes with either miR-378 depletion or treatment with sphingomyelinase inhibitor GW4869 enhanced the fibrotic responses of stimulated cardiac fibroblasts, confirming that miR-378 inhibits fibrosis in an extracellular vesicles-dependent secretory manner. Mechanistically, the miR-378-induced anti-fibrotic effects manifested partially through the suppression of p38 MAP kinase phosphorylation by targeting MKK6 in cardiac fibroblasts. Conclusions: miR-378 is secreted from cardiomyocytes following mechanical stress and acts as an inhibitor of excessive cardiac fibrosis through a paracrine mechanism.

MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

Abstract 49: Mir-21 Contributes to Cardiac Aging by Targeting Pten

Abstract 370: MicroRNA-19b Contributes to Cardiac Fibrosis

miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2

Impaired regulation of MMP2/16–MLCK3 by miR-146a-5p increased susceptibility to myocardial ischaemic injury in aging mice

miR-155-5p inhibition rejuvenates aged mesenchymal stem cells and enhances cardioprotection following infarction.

Cardiac Tissue-Resident Vesicles Differentially Modulate Anti-fibrotic Phenotype by Age and Sex Through Synergistic Mirna Effects

MiR‐203 improves cardiac dysfunction by targeting PARP1‐NAD+ axis in aging murine

Mir-21 Suppression Prevents Cardiac Alterations Induced by D-Galactose and Doxorubicin.

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Mineralocorticoid receptor promotes cardiac macrophage inflammaging

Role of Mirnas in Skeletal Muscle Aging

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging

MicroRNA expression with “aging” in human aortic endothelial cells

G-MDSCs promote aging-related cardiac fibrosis by activating myofibroblasts and preventing senescence

MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.

MicroRNA-34a Induces Vascular Smooth Muscle Cells Senescence by SIRT1 Downregulation and Promotes the Expression of Age-Associated Pro-inflammatory Secretory Factors.